Leaflet PRONATIV 500UI powder+solvent for solution for infusion
Indicated for: bleeding; coagulation disorders
Route of administration: infusion
Substance: coagulation factors (anticoagulant)
ATC: B02BD01 (Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Coagulation factors are essential proteins involved in the process of stopping bleeding, playing a key role in blood clot formation. Deficiency or dysfunction of these factors can lead to bleeding disorders such as hemophilia or von Willebrand disease. Treatment with coagulation factors is used to prevent or stop bleeding in people with such conditions.
Coagulation factors are administered intravenously under medical supervision, with the dose determined by the severity of the deficiency and the type of bleeding event. Treatment can be given preventively or as needed, for example during surgeries or after injuries.
Side effects may include allergic reactions, fever, headaches, or, rarely, the development of antibodies that can reduce the effectiveness of the treatment. Careful monitoring of the patient is essential to quickly detect any adverse reactions and adjust the treatment if necessary.
Therapy with coagulation factors has significantly improved the quality of life for patients with bleeding disorders. Following medical advice and being informed about possible risks contribute to safe and effective treatment.
General data about PRONATIV 500UI
- Substance: coagulation factors
- Date of last drug list: 01-06-2026
- Commercial code: W65359002
- Concentration: 500UI
- Pharmaceutical form: powder+solvent for solution for infusion
- Quantity: 1
- Product type: original
- Price: 1199.42 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for coagulation factors
Concentrations available for coagulation factors
- 1000UI
- 500UI
- 600UI